321 related articles for article (PubMed ID: 36009453)
1. The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism.
Sanguinetti C; Minniti M; Susini V; Caponi L; Panichella G; Castiglione V; Aimo A; Emdin M; Vergaro G; Franzini M
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009453
[TBL] [Abstract][Full Text] [Related]
2. A Narrative Review of the Role of Transthyretin in Health and Disease.
Liz MA; Coelho T; Bellotti V; Fernandez-Arias MI; Mallaina P; Obici L
Neurol Ther; 2020 Dec; 9(2):395-402. PubMed ID: 33001386
[TBL] [Abstract][Full Text] [Related]
3. Trapping the monomer of a non-amyloidogenic variant of transthyretin: exploring its possible use as a therapeutic strategy against transthyretin amyloidogenic diseases.
Palhano FL; Leme LP; Busnardo RG; Foguel D
J Biol Chem; 2009 Jan; 284(3):1443-53. PubMed ID: 18984591
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and Treatment Approaches Involving Transthyretin in Amyloidogenic Diseases.
Park GY; Jamerlan A; Shim KH; An SSA
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216785
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin: Its function and amyloid formation.
Ueda M
Neurochem Int; 2022 May; 155():105313. PubMed ID: 35218869
[TBL] [Abstract][Full Text] [Related]
6. A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis).
Gonzalez-Duarte A; Ulloa-Aguirre A
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884963
[TBL] [Abstract][Full Text] [Related]
7. Role of Saturation and Length of Fatty Acids of Phosphatidylserine in the Aggregation of Transthyretin.
Ali A; Zhaliazka K; Dou T; Holman AP; Kurouski D
ACS Chem Neurosci; 2023 Sep; 14(18):3499-3506. PubMed ID: 37676231
[TBL] [Abstract][Full Text] [Related]
8. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis.
Raghu P; Sivakumar B
Biochim Biophys Acta; 2004 Dec; 1703(1):1-9. PubMed ID: 15588697
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the Mechanisms Driving Transthyretin Amyloidosis.
Bezerra F; Saraiva MJ; Almeida MR
Front Mol Neurosci; 2020; 13():592644. PubMed ID: 33362465
[TBL] [Abstract][Full Text] [Related]
10. Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis.
Matsushita H; Misumi Y; Masuda T; Okada M; Inoue F; Ueda M; Ando Y
Pathophysiology; 2022 Jun; 29(3):333-343. PubMed ID: 35893595
[TBL] [Abstract][Full Text] [Related]
11. Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with Cardiomyopathy.
Ioannou A; Fontana M; Gillmore JD
Heart Int; 2023; 17(1):27-35. PubMed ID: 37456349
[TBL] [Abstract][Full Text] [Related]
12. Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?
Saponaro F; Kim JH; Chiellini G
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212973
[TBL] [Abstract][Full Text] [Related]
13. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
Paton DM
Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
[TBL] [Abstract][Full Text] [Related]
14. Retinol-Binding Protein Interferes with Transthyretin-Mediated β-Amyloid Aggregation Inhibition.
Mangrolia P; Murphy RM
Biochemistry; 2018 Aug; 57(33):5029-5040. PubMed ID: 30024734
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel transthyretin mutation D39Y in a cardiac amyloidosis patient and its biochemical characterizations.
Ma Q; Wang M; Huang Y; Nie Y; Zhang X; Yang DD; Wang Z; Ding S; Qian N; Liu Y; Pan X
Front Cardiovasc Med; 2023; 10():1091183. PubMed ID: 36776255
[TBL] [Abstract][Full Text] [Related]
16. Calcium Binds to Transthyretin with Low Affinity.
Cantarutti C; Mimmi MC; Verona G; Mandaliti W; Taylor GW; Mangione PP; Giorgetti S; Bellotti V; Corazza A
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008960
[TBL] [Abstract][Full Text] [Related]
17. Transthyretin: roles in the nervous system beyond thyroxine and retinol transport.
Oliveira SM; Cardoso I; Saraiva MJ
Expert Rev Endocrinol Metab; 2012 Mar; 7(2):181-189. PubMed ID: 30764010
[TBL] [Abstract][Full Text] [Related]
18. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
19. Saturation of fatty acids in phosphatidic acid uniquely alters transthyretin stability changing morphology and toxicity of amyloid fibrils.
Ali A; Zhaliazka K; Dou T; Holman AP; Kurouski D
Chem Phys Lipids; 2023 Nov; 257():105350. PubMed ID: 37858615
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin mutagenesis: impact on amyloidogenesis and disease.
Almeida ZL; Vaz DC; Brito RMM
Crit Rev Clin Lab Sci; 2024 Jun; ():1-25. PubMed ID: 38850014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
